FUNDED GRANTS AND CONTRACTS

Jonathan A. Doorn, PI, has received funding from NIH in the amount of $99,499, “Protein Modification by 3,4-Dihydroxyphenylacetaldehyde.”

John M. Brooks, Julie M. Urmie, William Doucette, Elizabeth Chrischilles, Geoffred McLennan, Jane Pendergast, Karl Thomas, Charles Lynch, Michele West, co-investigators (Robert Wallace, PI, $739,307) NIH, “Lung Cancer Care Outcomes/Surveillance Consortium – Iowa.”

John M. Brooks, Elizabeth Chrischilles, David Lubaroff, George Weiner, and Raymond Hohl, co-investigators (Robert Wallace, PI, $623,910) NIH, “Integrating Aging and Cancer Research.”

Barry Carter, PI, [co-investigators William Doucette, Elizabeth Chrischilles, Arthur Hartz, Jessica Milchak, and Paul James] has received funding from NIH in the amount of $638,555, “Improving Adherence to Blood Pressure Guidelines.” 

Barry Carter, PI, has received funding from the Iowa City Veterans Affairs Research Foundation in the amount of $16,299, “ICVARF-010.” 

Zhendong Jin, PI, has received funding from CLL Global Research Foundation in the amount of $25,000, “Preparation of OSW-1.”

Bradley Phillips, Mark Chapleau, Alan Johnson, Robert Weiss, Curt Sigmund, Robin Davission, William Haynes, Allyn Mark, Christopher Benson, Peter Snyder, Kevin Kregel, Andrew Russo, Frank Faraci, Baoli Yang, Ramesh Bhalla, Ram Vir Sharma, Beverly Davidson, co-investigators (Francois Abboud, PI, $1,870,242) NIH, “Integrative Neurobiology of Cardiovascular Regulation.”

Thomas E. Prisinzano, PI, has received funding from NIH in the amount of $342,500, “Investigation of Neoclerodanes as Novel Opioid Ligands.”

Kevin Tidgewell (Thomas E. Prisinzano, faculty mentor) has received funding from AFPE in the amount of $6,000, “Design, Synthesis and Evaluation of Novel Opioid Ligands Based on the Neoclerodane Diterpene, Salvinorin A.”

Vicki Ellingrod Ringold, PI, has received funding from NIH in the amount of $147,086, “Genetics of Antipsychtoic Metabolism.”

Molly Sinclair (Kevin Rice, faculty mentor) has received funding from AFPE in the amount of $6,000, “Design and Testing on Intrinsic Proteasome Inhibitors to Increase Gene Transfer Efficiency.”

Garett Rettig (Kevin Rice, faculty mentor) has received funding from AFPE in the amount of $6,000, “Development of PLGA Implantable Sponges as Novel Gene Delivery Vehicles.”

Kevin Rice, PI, has received funding from NIH in the amount of $221,250, “Sulfhydryl Cross-Linked Targeted Gene Delivery.”

Aliasger K. Salem, PI, has received funding from Pharmaceutical Research & Manufacturers of America Foundation in the amount of $30,000.